Item: Tata India Pharma & Healthcare Fund Direct Growth
Rating: Unrated
Author: Morningstar

Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth

19.259 (0.883%)

NAV on June 01, 2023

Category Equity:
Sector - Healthcare

Investment StyleBox

Large Growth

Total Assets 512 cr

Turnover Ratio 32.08%

Expense Ratio 1.00%

Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days

Returns

1M: 3.70%
1Y: 10.54%
3M: 9.48%
3Y: 17.11%
6M: 0.28%
5Y: 18.01%

Min Investment 5,000

Buy Now Start SIP

SECTOR WEIGHTINGS (%)

Financial 0.0%

Industrial 0.0%

Technology 0.0%

Basic Materials 0.0%

Consumer Cyclical 0.0%

Utilities Services 0.0%

Healthcare Services 100.00%

Energy Services 0.00%

Communication Services 0.00%

Consumer Defensive 0.00%

Real Estate 0.00%

INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

Top Rated
Top Performing

-

Best Sector Healthcare Funds

NAME	LATEST NAV	RETURNS 1y	FUND ASSETS	Expense RATIO	RISK
SBI Healthcare Opportunities Fund Direct Growth	265.590	18.05%	1,638 cr	—	-
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth	21.350	10.68%	2,552 cr	1.21%	-